A Pb 3 Mn 7 O 15 single crystal has been grown by the flux method and studied using x-ray diffraction and magnetization measurements. The crystal is hexagonal (P6 3 /mcm space group, Z = 4) and exhibits a pronounced layered nature. Along the [001] direction (c axis), the structure consists of layers of edge-sharing MnO 6 octahedra. Pairs of Mn atoms occupy the octahedral sites located between layers forming 'bridges' along the c axis, which link neighboring Mn layers. The magnetic properties of the crystal have been investigated using ac and dc magnetization measurements in the temperature range 2-900 K at magnetic fields up to 90 kOe. The experimental data obtained suggest that in the temperature region under study several different magnetic phases can be distinguished. Down to ∼250 K, the crystal is in the paramagnetic state. Below this temperature, short-range antiferromagnetic ordering apparently starts forming within Mn layers, although a transition to long-range magnetic order occurs at 70 K. The magnetization data obtained leads us to conclude that this state is canted antiferromagnetic with moments lying in the basal plane of the crystal. In addition, below 20 K the crystal undergoes one more magnetic transition that corresponds to spin reorientation.
The conditions for the flux growth of new Mn-Ni oxyborates with the ludwigite structure are reported. Magnetic measurement data for the samples with nickel and manganese predominance are presented. Diamagnetic anomalies of the antiferromagnetic phases are established and analyzed in the framework of a model comprising two antiferromagnetically interacting subsystems, each being antiferromagnetically ordered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.